News for Bavarian Nordic A/S (BVNKF)

Published at

Mar 5, 2025 8:05 PM

by seekingalpha.com

positive

positive

Bavarian Nordic A/S (BVNKF) Q4 2024 Earnings Call Transcript

Bavarian Nordic A/S (OTCPK:BVNKF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ETCompany ParticipantsRolf Sass Sorensen - Head, Investor...

BVNRY BVNKF

Read more →
Published at

Mar 5, 2025 8:15 AM

by manilatimes.net

neutral

neutral

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

**media[557583]**

BVNRY BVNKF

Read more →
Published at

Mar 5, 2025 8:14 AM

by manilatimes.net

neutral

neutral

Bavarian Nordic Publishes Annual Report 2024

**media[557568]**

BVNRY BVNKF

Read more →
Published at

Feb 28, 2025 5:32 PM

by manilatimes.net

positive

positive

Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older

**media[553759]**

BVNRY BVNKF

Read more →
Published at

Feb 25, 2025 7:07 AM

by manilatimes.net

negative

negative

Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine

**media[549238]**

BVNRY BVNKF

Read more →
Published at

Feb 14, 2025 11:50 PM

by manilatimes.net

positive

positive

Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older

**media[541186]**

BVNRY BVNKF

Read more →
Published at

Feb 3, 2025 6:48 PM

by manilatimes.net

neutral

neutral

Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025

**media[531058]**

BVNRY BVNKF

Read more →
Published at

Jan 31, 2025 8:41 PM

by manilatimes.net

positive

positive

Bavarian Nordic - Completion of Share Buy-Back Program

**media[529305]**

BVNRY BVNKF

Read more →
Published at

Jan 31, 2025 11:57 AM

by manilatimes.net

positive

positive

Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older

**media[528906]**

BVNRY BVNKF

Read more →
Published at

Jan 29, 2025 6:43 PM

by manilatimes.net

neutral

neutral

BioPorto A/S appoints new interim Chairman of the Board

**media[527539]**

THOXF BVNRY BVNKF 0JJM.L

Read more →
Published at

Jan 27, 2025 7:38 AM

by manilatimes.net

positive

positive

Bavarian Nordic - Transactions in Connection with Share Buy-Back Program

**media[524720]**

BVNRY BVNKF

Read more →
Published at

Jan 20, 2025 7:32 AM

by manilatimes.net

positive

positive

Bavarian Nordic - Transactions in Connection with Share Buy-Back Program

**media[518981]**

BVNRY BVNKF

Read more →
Published at

Jan 9, 2025 8:24 AM

by manilatimes.net

positive

positive

Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million

**media[510403]**

DNSKF DNKEY BVNRY BVNKF

Read more →
Published at

Dec 16, 2024 3:49 PM

by thehindubusinessline.com

positive

positive

Bavarian Nordic enters licence, manufacturing agreement for its mpox vaccine with Serum Institute of India

Bavarian Nordic partners with Serum Institute of India for MVA-BN vaccine manufacturing, expanding global supply during mpox outbreaks.

BVNRY BVNKF

Read more →
Published at

Dec 16, 2024 7:45 AM

by manilatimes.net

positive

positive

Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India

**media[493026]**

BVNRY BVNKF

Read more →
Published at

Aug 23, 2024 9:30 PM

by seekingalpha.com

mixed

mixed

Undercovered Dozen: Delcath Systems, Bavarian Nordic, Tempus AI, Journey Energy +

Discover 12 curated investment ideas on stocks with less coverage, including energy, healthcare, and M&A opportunities. Read what investors need to know.

REPYY REPYF REPSN.MX REPA.DE REP.MI REP.MC REP.DE PAGS OWL FREY DNN DML.TO DCTH 0URY.L JRNGF JOY.TO BVNRY BVNKF

Read more →
Published at

Aug 15, 2024 1:46 PM

by zerohedge.com

mixed

mixed

Futures Rise Ahead Of Data Deluge Including Key Retail Sales Report

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

ULTA TITN MSCL.SN HOOD GLH.AX CSCO BRKBD.BA BRKBB.BA BRKB.BA AZN BVNRY BVNKF

Read more →
Published at

Jan 29, 2024 8:24 AM

by globenewswire.com

mixed

mixed

Global Meningococcal Vaccines Market to Reach Value of USD 4.98 Billion by 2030 | Skyquest Technology

Global meningococcal vaccines market is segmented by type, and end-user. The market can be segmented based on type into conjugate and polysaccharide...

ZEG.DE PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE AZNN.MX AZNCF AZN.L AZN 0A4J.L GSK.L GSK GS7.DE GLAXF NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK BVNRY BVNKF 6MK.DE 300142.SZ 300122.SZ 0K9E.L 002007.SZ

Read more →
Published at

Jul 21, 2023 10:06 AM

by globenewswire.com

mixed

mixed

Influenza Vaccine Market to Surpass 12.37 Billion by 2030 Drives Due to Growing Prevalence of Influenza Disease

SkyQuest projects that the influenza vaccine market will attain a USD 12.37 billion value by 2030, with a CAGR of 6.83% over the forecast period...

VXRT.MX VXRT NB11.DE MRNA.MX MRNA M1RN34.SA CSLN.MX CSLLY CSL.AX CMXHF ALT1.MX ALT 0A4C.L 0A45.L REGN34.SA REGN.MX REGN DSNKY DSKYF BVXV BVNRY BVNKF ABTCL.SN ABT.SN ABT 4568.T 0R2M.L 002007.SZ JNJ DJNJ3.BA DJNJ2.BA

Read more →
Published at

May 23, 2023 7:00 PM

by globenewswire.com

mixed

mixed

mRNA Vaccines And Therapeutics Global Market to Show Decline in Growth at a CAGR of ~-34% by 2028 | DelveInsight

The rising demand for protection against sudden pandemic outbreaks, the growing patient pool associated with infectious diseases around the world, and the...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MRNA.MX MRNA MRKD.BA MRK.SN MRK.PA MRK.MX MRK M1RN34.SA BVNRY BVNKF 6MK.DE 0A45.L MTLHY MTLHF BNTXN.MX BNTX ARGS ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE 4188.T 0A3M.L

Read more →